Karen Becker

9.1k total citations · 3 hit papers
96 papers, 6.9k citations indexed

About

Karen Becker is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Karen Becker has authored 96 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pulmonary and Respiratory Medicine, 55 papers in Surgery and 42 papers in Oncology. Recurrent topics in Karen Becker's work include Gastric Cancer Management and Outcomes (52 papers), Esophageal Cancer Research and Treatment (35 papers) and Gastrointestinal Tumor Research and Treatment (17 papers). Karen Becker is often cited by papers focused on Gastric Cancer Management and Outcomes (52 papers), Esophageal Cancer Research and Treatment (35 papers) and Gastrointestinal Tumor Research and Treatment (17 papers). Karen Becker collaborates with scholars based in Germany, Switzerland and United States. Karen Becker's co-authors include Katja Ott, U. Fink, Heinz Höfler, Markus Schwaiger, Florian Lordick, Wolfgang Weber, J. R. Siewert, Rupert Langer, Raymonde Busch and Jörg‐Rüdiger Siewert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Karen Becker

93 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

2003 603 citations Karen Becker, Katja Ott et al. profile →
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

2007 550 citations Florian Lordick, Katja Ott et al. profile →
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging

2001 523 citations Wolfgang Weber, Katja Ott et al. profile →

Peers

Countries citing papers authored by Karen Becker

Since Specialization

Citations

This map shows the geographic impact of Karen Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Becker more than expected).

Fields of papers citing papers by Karen Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Becker. The network helps show where Karen Becker may publish in the future.

Co-authorship network of co-authors of Karen Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Becker. A scholar is included among the top collaborators of Karen Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Becker. Karen Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pegvaliase dose escalation in adult with PKU: A case report update 2024 ·Molecular Genetics and Metabolism ·(unknown), (unknown), Karen Becker, (unknown)	0
2	MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus 2018 ·Journal of Translational Medicine ·Julia Slotta‐Huspenina, Enken Drecoll, Marcus Feith, Daniel Habermehl, Stephanie E. Combs, Wilko Weichert, Marcus Bettstetter, Karen Becker, Rupert Langer	36
3	Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy 2017 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Rupert Langer, Karen Becker	82
4	Maffucci syndrome and neoplasms: a case report and review of the literature 2016 ·BMC Research Notes ·Olga Prokopchuk, (unknown), Karen Becker, Konstantin Holzapfel, Daniel Hartmann, Helmut Frieß	29
5	Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy report 2016 ·Digestive and Liver Disease ·Heather Dawson, Alexander Novotny, Karen Becker, Daniel Reim, Rupert Langer, Irene Gullo, Magali Svrcek, Jan Hendrik Niess, Radu Țuțuian, Kaspar Truninger, Ioannis Diamantis, Annika Blank, Inti Zlobec, Robert H. Riddell, Fátima Carneiro, Jean–François Fléjou, Robert M. Genta, Alessandro Lugli	7
6	Cisplatin fails to induce puma mediated apoptosis in mucosal melanomas 2015 ·Oncotarget ·(unknown), (unknown), Karen Becker, (unknown), Clemens Heiser, Benedikt Hofauer, Andreas Knopf	5
7	Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas 2013 ·PLoS ONE ·Sabina Berezowska, Alexander Novotny, (unknown), Annette Feuchtinger, Julia Slotta‐Huspenina, Karen Becker, Rupert Langer, Axel Walch	24
8	The Severity of Neural Invasion Is Associated with Shortened Survival in Colon Cancer 2012 ·Clinical Cancer Research ·Florian Liebl, İhsan Ekin Demir, Robert Rosenberg, (unknown), (unknown), (unknown), Timo Kehl, (unknown), Tibor Schuster, Matthias Maak, Karen Becker, Rupert Langer, Melanie Laschinger, Helmut Frieß, Güralp O. Ceyhan	78
9	Pancreatic-type acinar cell carcinoma of the liver: a clinicopathologic study of four patients 2011 ·Modern Pathology ·Abbas Agaimy, A. Kaiser, Karen Becker, Jan Hinrich Bräsen, Peter H. Wünsch, Volkan Adsay, Günter Klöppel	20
10	Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer 2011 ·Annals of Surgical Oncology ·Katja Ott, Ken Herrmann, Tibor Schuster, Rupert Langer, Karen Becker, Hinrich Wieder, Hans‐Jürgen Wester, Jörg‐Rüdiger Siewert, Christian Meyer zum Büschenfelde, Andreas K. Buck, Dirk Wilhelm, Matthias P. Ebert, Christian Peschel, Markus Schwaiger, Florian Lordick, Bernd J. Krause	46
11	Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer 2010 ·Annals of Surgical Oncology ·Kathrin Mutze, Rupert Langer, Karen Becker, Katja Ott, Alexander Novotny, Birgit Luber, Alexander Hapfelmeier, Martin Göttlicher, Heinz Höfler, Gisela Keller	61
12	Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study 2010 ·Journal of Clinical Pathology ·Rupert Langer, Kathrin Mutze, Karen Becker, Marcus Feith, Katja Ott, Heinz Höfler, Gisela Keller	29
13	The Severity of Neural Invasion Is a Crucial Prognostic Factor in Rectal Cancer Independent of Neoadjuvant Radiochemotherapy 2010 ·Annals of Surgery ·Güralp O. Ceyhan, Florian Liebl, Matthias Maak, Tibor Schuster, Karen Becker, Rupert Langer, İhsan Ekin Demir, Mark Hartel, Helmut Frieß, Robert Rosenberg	59
14	Protein Expression Profiling in Esophageal Adenocarcinoma Patients Indicates Association of Heat-Shock Protein 27 Expression and Chemotherapy Response 2008 ·Clinical Cancer Research ·Rupert Langer, Katja Ott, Katja Specht, Karen Becker, Florian Lordick, Maria Burian, Ken Herrmann, André Schrattenholz, Michael A. Cahill, Markus Schwaiger, Heinz Höfler, Hans‐Jürgen Wester	49
15	The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT 2008 ·International Journal of Colorectal Disease ·Robert Rosenberg, Ken Herrmann, Ralf Gertler, Beat Künzli, Markus Essler, Florian Lordick, Karen Becker, Tibor Schuster, Hans Geinitz, Matthias Maak, Markus Schwaiger, Jörg‐Rüdiger Siewert, Bernd J. Krause	74
16	Comparison of Pretherapeutic and Posttherapeutic Expression Levels of Chemotherapy-Associated Genes in Adenocarcinomas of the Esophagus Treated by 5-Fluorouracil– and Cisplatin-Based Neoadjuvant Chemotherapy 2007 ·American Journal of Clinical Pathology ·Rupert Langer, Katja Specht, Karen Becker, (unknown), Katja Ott, Florian Lordick, Jörg‐Rüdiger Siewert, Heinz Höfler	19
17	PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·Hinrich Wieder, Hans Geinitz, Robert Rosenberg, Florian Lordick, Karen Becker, Alexander Stahl, Ernst J. Rummeny, J. R. Siewert, Markus Schwaiger, J. Stollfuß	91
18	Esophageal Replacement by Lexer’s Esophagoplasty: Adenocarcinoma as Late Complication 2005 ·The Annals of Thoracic Surgery ·Alexander Novotny, G. Florack, Karen Becker, Jörg‐Rüdiger Siewert	0
19	FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings 2003 ·European Journal of Nuclear Medicine and Molecular Imaging ·Alexander Stahl, Katja Ott, Wolfgang Weber, Karen Becker, Thomas M. Link, Jörg‐Rüdiger Siewert, Markus Schwaiger, U. Fink	243
20	Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight cases 1996 ·Journal of Thoracic and Cardiovascular Surgery ·Paul M. Schneider, Alan G. Casson, Bernard Levin, Harinder S. Garewal, Arnulf H. Hoelscher, Karen Becker, H. J. Dittler, Karen R. Cleary, Michael Troster, J. R. Siewert, Jack A. Roth	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact